Status:

COMPLETED

A Study of LY3454738 in Healthy Participants and Participants With Atopic Dermatitis

Lead Sponsor:

Eli Lilly and Company

Conditions:

Dermatitis, Atopic

Eligibility:

All Genders

18-65 years

Phase:

PHASE1

Brief Summary

The main purpose of this study is to investigate the safety, tolerability, and efficacy of the study drug known as LY3454738 in healthy participants and participants with atopic dermatitis. The study ...

Eligibility Criteria

Inclusion

  • All: Must have a body mass index of 18.0 to 32.0 kilograms per square meter (kg/m²), inclusive, for Parts A and B, and 18.0 to 45.0 kg/m², inclusive, for Part C and a minimum body weight of 50 kilograms
  • For PART A and B only, regarding the inclusion of healthy Japanese participants: Minimum age is 20 years and the participant's biological parents and all of the participant's biological grandparents must be of exclusive Japanese descent and must have been born in Japan
  • AD:
  • Must have a diagnosis of AD for at least 12 months with either poor response to topical treatments or inability to use topical treatments
  • Must agree to use moisturizer daily throughout the treatment period

Exclusion

  • All: must not have previously completed a clinical trial with a molecule targeting interleukin-33 (IL-33) or its receptor
  • AD:
  • Must not have received certain topical medications for AD within 2 weeks prior to randomization
  • Must not have received certain oral medications for AD or received phototherapy within 4 weeks prior to randomization
  • Must not have received any antibody-based biologic agents (marketed or investigational) within 5 half lives (t1/2) of the drug prior to randomization
  • Must not have received intravenous, intramuscular, or intra-articular steroids in the past 6 weeks prior to randomization

Key Trial Info

Start Date :

November 29 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 7 2021

Estimated Enrollment :

128 Patients enrolled

Trial Details

Trial ID

NCT03750643

Start Date

November 29 2018

End Date

September 7 2021

Last Update

October 6 2021

Active Locations (21)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 6 (21 locations)

1

Pinnacle Research Group

Anniston, Alabama, United States, 36207

2

Arkansas Research Trials, LLC

North Little Rock, Arkansas, United States, 72117

3

Northwest Arkansas Clinical Trials Center

Rogers, Arkansas, United States, 72758

4

First OC Dermatology

Fountain Valley, California, United States, 92708

A Study of LY3454738 in Healthy Participants and Participants With Atopic Dermatitis | DecenTrialz